IP Library › Assignment 069094/0505
Patent Assignment
Reel/Frame 069094/0505

Change of Name

Recorded: 2024-10-01 Pages: 4
Assignor
Assignee
SUMITOMO PHARMA ONCOLOGY, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property (1)
Substituted Imidazo[1,2-B]Pyridazines as Protein Kinase Inhibitors
Application: 18/741,526 →
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →
Assignment of Assignor's Interest Oct 1, 2024
From: XU, YONG; BRENNING, BENJAMIN GARY; KULTGEN, STEVEN G.; LIU, XIAOHUI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 069094/0247 →
Change of Name Oct 1, 2024
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 069094/0417 →
Merger Oct 1, 2024
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 068758/0057 →
Merger Oct 1, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068758/0193 →